Search

You searched for "Nigeria"

402 results found

In conversation with Prof Carrie MacEwen, Chair of The Way Forward and President, The Royal College of Ophthalmologists

1 April 2017 | | EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - Cataract, EYE - Refractive, EYE - Orbit, EYE - Paediatrics, EYE - Strabismus, EYE - General
Prof Carrie MacEwen. Scope for optimising capacity within the Hospital Eye Service (HES)? The demand for ophthalmic care continues to grow with no increase in capacity. In order to be able to continue to deliver adequate care ophthalmologists have devised...

Quantum imaging research could improve retinal scans

28 October 2025 | OCT, Imaging, Diagnosis, research, Retina
New EU-funded feasibility project is testing a quantum approach that could reveal finer detail in the eye than ever before. A European research consortium is exploring a new quantum imaging technique that could one day help clinicians see the earliest...

Learning to see the bigger picture: Reflections from a cataract surgery course in the Middle East

5 June 2025 | | EYE - Cataract
Alcon, the Swiss-American company specialising in eyecare equipment, inaugurated their Alcon Experience Centre (AEC) in Jeddah, Saudi Arabia. AEC is an eye education and training centre for students and eyecare professionals. This is the first AEC catering to the Middle...

Crystalline keratopathy in monoclonal gammopathy of undetermined significance

2 April 2025 | | EYE - Cornea
Monoclonal gammopathies encompass a group of plasma cell disorders characterised by the excessive production of abnormal monoclonal immunoglobulins in the bloodstream [1]. This category includes multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), amyloidosis and other lymphoproliferative disorders. Monoclonal gammopathy...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital

1 August 2018 | | EYE - Cornea, EYE - General
The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...

Analysis of ‘urgent’ cataract referrals from community optometrists in the West of Scotland

3 June 2021 | | EYE - Cataract, EYE - Refractive
As elective cataract services restart post-COVID, how do we establish which patients should be a priority? The authors share their findings from a review of ‘urgent’ referrals received by the ophthalmology department in NHS Greater Glasgow & Clyde. The COVID-19...

Ophthalmology clinical teaching and research fellowships: a pathway into ophthalmology specialty training

25 January 2022 | | EYE - General
Ophthalmology is known for being one of the most competitive medical specialties in the UK, with 6.8 applicants per post in 2021. In fact, the competition ratio has drastically increased in recent years, rising from 5.73 in 2020 and 3.24...

Paediatric optic disc anomalies

4 December 2025 | | EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Paediatrics
Anomalies of the optic nerve are relatively rare, but account for a significant proportion of sight impairment in children and adults. The recognition of these anomalies by eye health professionals is important not only due to their potential impact on...

What not to miss in neuro-ophthalmology Part 2

1 August 2018 | EYE - Neuro-ophthalmology
As mentioned previously there are several conditions in neuro-ophthalmology that should not be missed by the general ophthalmologist as well as ophthalmology trainees. We discussed in the first part some of these conditions including third cranial nerve palsies, giant cell...

It’s not always GCA

7 December 2020 | | EYE - Neuro-ophthalmology, EYE - General
Giant cell arteritis (GCA) is an immune mediated granulomatous inflammatory disease that affects muscular middle or large sized arteries. It is considered as a continuation of polymyalgia rheumatica (PMR) when the severity of the disease has increased. It is the...

High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications

2 October 2025 | | EYE - Vitreo-Retinal, EYE - Glaucoma
Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...